Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou4f1
|
ENSMUSG00000048349.8 | POU domain, class 4, transcription factor 1 |
Pou6f1
|
ENSMUSG00000009739.10 | POU domain, class 6, transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_104465474_104466650 | Pou4f1 | 697 | 0.667712 | 0.49 | 7.2e-05 | Click! |
chr14_104466654_104466919 | Pou4f1 | 1213 | 0.450366 | 0.48 | 1.2e-04 | Click! |
chr14_104463807_104464161 | Pou4f1 | 1381 | 0.401507 | 0.44 | 5.1e-04 | Click! |
chr14_104464844_104465214 | Pou4f1 | 336 | 0.874285 | 0.43 | 6.2e-04 | Click! |
chr14_104464182_104464605 | Pou4f1 | 972 | 0.533465 | 0.43 | 6.6e-04 | Click! |
chr15_100599026_100600047 | Pou6f1 | 328 | 0.627346 | 0.32 | 1.2e-02 | Click! |
chr15_100572656_100572807 | Pou6f1 | 7500 | 0.099484 | 0.11 | 4.2e-01 | Click! |
chr15_100585124_100585275 | Pou6f1 | 987 | 0.346022 | 0.08 | 5.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_34654574_34655689 | 17.26 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
905 |
0.42 |
chr8_109245493_109246323 | 16.02 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
3958 |
0.33 |
chr7_16134834_16135297 | 14.53 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
4717 |
0.13 |
chr15_92160888_92162023 | 13.99 |
Cntn1 |
contactin 1 |
98 |
0.98 |
chr18_43389837_43390467 | 13.31 |
Dpysl3 |
dihydropyrimidinase-like 3 |
3225 |
0.29 |
chr7_51629095_51630495 | 13.26 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
315 |
0.88 |
chr12_29529828_29531185 | 12.75 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr13_83739310_83740387 | 12.62 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
985 |
0.29 |
chr3_76075315_76075943 | 12.58 |
Fstl5 |
follistatin-like 5 |
46 |
0.98 |
chrX_23294952_23295287 | 12.53 |
Klhl13 |
kelch-like 13 |
1039 |
0.66 |
chr1_66323360_66324079 | 12.36 |
Map2 |
microtubule-associated protein 2 |
1617 |
0.37 |
chr1_42702274_42702636 | 11.80 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
5597 |
0.14 |
chr4_78209143_78209724 | 11.66 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
2306 |
0.29 |
chr3_84953332_84953942 | 11.58 |
Fbxw7 |
F-box and WD-40 domain protein 7 |
1491 |
0.53 |
chr16_77421091_77421970 | 10.93 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
290 |
0.84 |
chr1_66322405_66322814 | 10.91 |
Map2 |
microtubule-associated protein 2 |
507 |
0.79 |
chr2_77701567_77703605 | 10.87 |
Zfp385b |
zinc finger protein 385B |
686 |
0.8 |
chr15_40533600_40534035 | 10.60 |
Gm7382 |
predicted gene 7382 |
3504 |
0.28 |
chr13_34126566_34127191 | 10.11 |
Tubb2b |
tubulin, beta 2B class IIB |
3476 |
0.13 |
chr17_80946268_80946852 | 9.66 |
Tmem178 |
transmembrane protein 178 |
1928 |
0.35 |
chr3_17783692_17784517 | 9.52 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
5817 |
0.2 |
chr10_12613847_12614341 | 9.43 |
Utrn |
utrophin |
737 |
0.78 |
chr4_110283517_110283754 | 9.40 |
Elavl4 |
ELAV like RNA binding protein 4 |
2981 |
0.39 |
chr8_109248831_109249717 | 9.25 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
592 |
0.83 |
chr15_44705107_44706053 | 9.18 |
Sybu |
syntabulin (syntaxin-interacting) |
42208 |
0.15 |
chr6_55678280_55679200 | 9.00 |
Neurod6 |
neurogenic differentiation 6 |
2523 |
0.32 |
chr13_101234142_101234529 | 8.91 |
5930438M14Rik |
RIKEN cDNA 5930438M14 gene |
2208 |
0.35 |
chr2_170733371_170733888 | 8.90 |
Dok5 |
docking protein 5 |
1822 |
0.45 |
chr4_109342938_109343450 | 8.89 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
59 |
0.97 |
chr4_110290101_110291006 | 8.72 |
Elavl4 |
ELAV like RNA binding protein 4 |
281 |
0.95 |
chr13_83726534_83727321 | 8.59 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1179 |
0.35 |
chr19_47017205_47017356 | 8.50 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
2127 |
0.2 |
chr17_91085493_91086001 | 8.46 |
Gm47307 |
predicted gene, 47307 |
2659 |
0.21 |
chr5_131534533_131535200 | 8.43 |
Auts2 |
autism susceptibility candidate 2 |
469 |
0.81 |
chr11_24096920_24097550 | 8.35 |
Bcl11a |
B cell CLL/lymphoma 11A (zinc finger protein) |
16565 |
0.13 |
chr13_84905458_84906287 | 8.34 |
Gm4059 |
predicted gene 4059 |
68445 |
0.12 |
chr16_77236731_77239778 | 8.30 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
1935 |
0.4 |
chr3_13472022_13472431 | 8.21 |
Gm2464 |
predicted gene 2464 |
397 |
0.59 |
chr9_43069907_43070263 | 8.16 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
27453 |
0.17 |
chr9_58197310_58202560 | 8.14 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr3_73052207_73052615 | 8.10 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
4532 |
0.2 |
chr2_143547529_143548278 | 8.06 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
66 |
0.97 |
chr15_18819772_18819999 | 8.04 |
Cdh10 |
cadherin 10 |
444 |
0.76 |
chr13_29014902_29016014 | 8.03 |
A330102I10Rik |
RIKEN cDNA A330102I10 gene |
835 |
0.7 |
chr3_67892808_67893503 | 7.99 |
Iqschfp |
Iqcj and Schip1 fusion protein |
923 |
0.42 |
chr7_128690432_128691249 | 7.94 |
Gm16044 |
predicted gene 16044 |
1849 |
0.17 |
chr17_93201490_93204144 | 7.93 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
741 |
0.65 |
chr4_105170584_105171640 | 7.86 |
Plpp3 |
phospholipid phosphatase 3 |
13765 |
0.26 |
chr10_29143400_29144848 | 7.83 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr7_99383478_99385192 | 7.80 |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
1563 |
0.33 |
chr3_115774354_115774995 | 7.75 |
Gm9889 |
predicted gene 9889 |
59524 |
0.1 |
chr13_83732205_83734272 | 7.68 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr1_137901653_137901959 | 7.68 |
Gm4258 |
predicted gene 4258 |
3208 |
0.12 |
chr5_70842167_70842810 | 7.68 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
129 |
0.98 |
chr18_59062200_59063436 | 7.65 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
307 |
0.94 |
chr13_28420292_28420642 | 7.63 |
Gm40841 |
predicted gene, 40841 |
401 |
0.89 |
chr7_4120918_4121688 | 7.58 |
9430041J12Rik |
RIKEN cDNA 9430041J12 gene |
575 |
0.45 |
chr18_77562293_77562757 | 7.55 |
Rnf165 |
ring finger protein 165 |
2084 |
0.37 |
chr13_109927479_109928182 | 7.53 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
986 |
0.65 |
chr19_38266301_38266452 | 7.50 |
Lgi1 |
leucine-rich repeat LGI family, member 1 |
966 |
0.51 |
chr4_91380440_91381612 | 7.46 |
Elavl2 |
ELAV like RNA binding protein 1 |
4530 |
0.22 |
chr8_47286544_47286695 | 7.44 |
Stox2 |
storkhead box 2 |
2743 |
0.33 |
chr2_116055788_116056761 | 7.41 |
Meis2 |
Meis homeobox 2 |
2568 |
0.25 |
chr17_83792570_83792796 | 7.37 |
Mta3 |
metastasis associated 3 |
2739 |
0.29 |
chrX_166344665_166345995 | 7.35 |
Gpm6b |
glycoprotein m6b |
488 |
0.85 |
chr16_77416103_77416788 | 7.35 |
Gm38071 |
predicted gene, 38071 |
179 |
0.91 |
chrX_152643367_152644550 | 7.30 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr1_99774053_99774267 | 7.29 |
Cntnap5b |
contactin associated protein-like 5B |
1395 |
0.49 |
chr11_94045498_94046076 | 7.27 |
Spag9 |
sperm associated antigen 9 |
1422 |
0.4 |
chr2_52557337_52558561 | 7.25 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
611 |
0.74 |
chr6_90781027_90782541 | 7.19 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
188 |
0.94 |
chr5_84414084_84414723 | 7.15 |
Epha5 |
Eph receptor A5 |
2403 |
0.37 |
chr12_27336415_27336825 | 7.12 |
Sox11 |
SRY (sex determining region Y)-box 11 |
5954 |
0.3 |
chr4_24429901_24430719 | 7.12 |
Gm27243 |
predicted gene 27243 |
580 |
0.79 |
chr10_119820571_119821220 | 7.07 |
Grip1 |
glutamate receptor interacting protein 1 |
1370 |
0.48 |
chr4_116223265_116224130 | 7.07 |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
2001 |
0.23 |
chr13_83742301_83742867 | 7.06 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3721 |
0.15 |
chr8_12324957_12325822 | 6.93 |
Gm33175 |
predicted gene, 33175 |
5909 |
0.18 |
chr12_29529268_29529419 | 6.91 |
Myt1l |
myelin transcription factor 1-like |
942 |
0.56 |
chr17_46255044_46255454 | 6.89 |
Lrrc73 |
leucine rich repeat containing 73 |
1059 |
0.3 |
chr4_28143186_28143619 | 6.87 |
Gm11911 |
predicted gene 11911 |
76225 |
0.11 |
chr2_180890379_180892235 | 6.77 |
Gm14342 |
predicted gene 14342 |
1647 |
0.19 |
chr19_38348426_38349048 | 6.76 |
Gm50150 |
predicted gene, 50150 |
6123 |
0.16 |
chr3_34658275_34659470 | 6.75 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
2836 |
0.15 |
chr7_140821200_140821421 | 6.70 |
Zfp941 |
zinc finger protein 941 |
822 |
0.35 |
chr10_69536775_69537233 | 6.61 |
Ank3 |
ankyrin 3, epithelial |
2782 |
0.32 |
chr10_94941542_94941964 | 6.59 |
Plxnc1 |
plexin C1 |
3082 |
0.28 |
chr4_33927772_33928010 | 6.58 |
Cnr1 |
cannabinoid receptor 1 (brain) |
1689 |
0.47 |
chr3_88206822_88208169 | 6.57 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chrX_6171274_6171425 | 6.57 |
Nudt10 |
nudix (nucleoside diphosphate linked moiety X)-type motif 10 |
1666 |
0.4 |
chr12_70109243_70109882 | 6.56 |
Nin |
ninein |
2009 |
0.27 |
chr16_77418973_77419718 | 6.54 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
2475 |
0.17 |
chr13_8207058_8207829 | 6.54 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
4521 |
0.2 |
chr3_13470890_13471041 | 6.52 |
Ralyl |
RALY RNA binding protein-like |
690 |
0.51 |
chrX_166346283_166346827 | 6.49 |
Gpm6b |
glycoprotein m6b |
1713 |
0.43 |
chr1_98047392_98048201 | 6.42 |
B230216N24Rik |
RIKEN cDNA B230216N24 gene |
3 |
0.97 |
chr11_87759834_87761999 | 6.42 |
Tspoap1 |
TSPO associated protein 1 |
329 |
0.75 |
chr4_13753841_13754203 | 6.40 |
Runx1t1 |
RUNX1 translocation partner 1 |
2725 |
0.4 |
chr3_119154592_119155474 | 6.36 |
Gm43410 |
predicted gene 43410 |
286789 |
0.01 |
chr3_68573207_68574269 | 6.36 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chr13_72815978_72817181 | 6.35 |
D730050B12Rik |
RIKEN cDNA D730050B12 gene |
184 |
0.96 |
chrX_158924759_158924985 | 6.26 |
Gm5764 |
predicted gene 5764 |
91437 |
0.09 |
chr18_81165961_81166641 | 6.22 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
69765 |
0.09 |
chr1_54555725_54555986 | 6.19 |
Pgap1 |
post-GPI attachment to proteins 1 |
1772 |
0.33 |
chr13_78193022_78193812 | 6.18 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
2956 |
0.18 |
chr9_91404809_91406365 | 6.18 |
Gm29478 |
predicted gene 29478 |
1113 |
0.42 |
chr5_111425949_111427685 | 6.13 |
Gm43119 |
predicted gene 43119 |
3228 |
0.22 |
chr13_84905027_84905302 | 6.12 |
Gm4059 |
predicted gene 4059 |
69153 |
0.12 |
chr10_69465826_69466044 | 6.10 |
Gm18636 |
predicted gene, 18636 |
42187 |
0.15 |
chr3_73055286_73056050 | 6.09 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
1275 |
0.44 |
chr9_96728847_96729194 | 6.08 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
16 |
0.97 |
chr12_119235620_119236481 | 6.08 |
Itgb8 |
integrin beta 8 |
2720 |
0.31 |
chr3_127224567_127225242 | 6.07 |
Ank2 |
ankyrin 2, brain |
943 |
0.48 |
chr1_165933923_165934165 | 6.06 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
856 |
0.54 |
chrX_169827749_169828991 | 6.06 |
Mid1 |
midline 1 |
211 |
0.96 |
chr5_144760724_144761824 | 6.03 |
Tmem130 |
transmembrane protein 130 |
375 |
0.83 |
chr17_3610552_3611747 | 6.02 |
1700102H20Rik |
RIKEN cDNA 1700102H20 gene |
53280 |
0.12 |
chr5_37244380_37244680 | 6.02 |
Crmp1 |
collapsin response mediator protein 1 |
1234 |
0.48 |
chr14_122481884_122483266 | 5.98 |
Zic2 |
zinc finger protein of the cerebellum 2 |
4475 |
0.12 |
chr7_92234907_92236280 | 5.97 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr12_61525470_61525621 | 5.97 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
1597 |
0.38 |
chr3_34196316_34197672 | 5.96 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
130 |
0.97 |
chr10_110453550_110454045 | 5.95 |
Nav3 |
neuron navigator 3 |
2407 |
0.34 |
chr2_110949491_110950578 | 5.95 |
Ano3 |
anoctamin 3 |
338 |
0.92 |
chr10_20528856_20529318 | 5.94 |
Gm17229 |
predicted gene 17229 |
9319 |
0.21 |
chr6_136171767_136172200 | 5.92 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
94 |
0.95 |
chr7_51748704_51749396 | 5.92 |
Gm7336 |
predicted gene 7336 |
2403 |
0.28 |
chr5_8621275_8621443 | 5.89 |
Rundc3b |
RUN domain containing 3B |
1593 |
0.4 |
chr13_83736071_83736534 | 5.88 |
Gm33366 |
predicted gene, 33366 |
2233 |
0.18 |
chr5_107498136_107498752 | 5.85 |
Btbd8 |
BTB (POZ) domain containing 8 |
665 |
0.57 |
chr16_43504464_43505047 | 5.85 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1058 |
0.61 |
chr3_45384939_45386122 | 5.85 |
Pcdh10 |
protocadherin 10 |
2897 |
0.22 |
chr14_39469812_39470401 | 5.85 |
Nrg3 |
neuregulin 3 |
2560 |
0.44 |
chr7_128689234_128689975 | 5.79 |
Gm43580 |
predicted gene 43580 |
1069 |
0.26 |
chr8_54956010_54956394 | 5.79 |
Gpm6a |
glycoprotein m6a |
1359 |
0.38 |
chr9_41578714_41578969 | 5.78 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
653 |
0.53 |
chr14_24002097_24002465 | 5.77 |
4930519K11Rik |
RIKEN cDNA 4930519K11 gene |
1563 |
0.3 |
chr4_116404159_116404477 | 5.76 |
Mast2 |
microtubule associated serine/threonine kinase 2 |
1668 |
0.37 |
chr18_35213481_35213842 | 5.74 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
1269 |
0.34 |
chr17_91086370_91086959 | 5.71 |
Gm47307 |
predicted gene, 47307 |
1742 |
0.26 |
chr16_28927533_28927764 | 5.69 |
Mb21d2 |
Mab-21 domain containing 2 |
2025 |
0.41 |
chr13_109445560_109445945 | 5.66 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
3569 |
0.38 |
chr3_34197711_34199105 | 5.65 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1544 |
0.41 |
chr8_90345047_90345661 | 5.64 |
Tox3 |
TOX high mobility group box family member 3 |
2772 |
0.42 |
chr7_144898015_144898977 | 5.62 |
Gm26793 |
predicted gene, 26793 |
1035 |
0.34 |
chr9_60686843_60686994 | 5.61 |
Lrrc49 |
leucine rich repeat containing 49 |
616 |
0.74 |
chr12_52699823_52700029 | 5.55 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
543 |
0.8 |
chr8_40633333_40633515 | 5.48 |
Mtmr7 |
myotubularin related protein 7 |
1335 |
0.41 |
chr12_67218771_67218992 | 5.48 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
2161 |
0.43 |
chr18_31446492_31447667 | 5.46 |
Syt4 |
synaptotagmin IV |
327 |
0.87 |
chr19_6499251_6500132 | 5.45 |
Nrxn2 |
neurexin II |
1856 |
0.23 |
chr18_25750468_25751272 | 5.41 |
Celf4 |
CUGBP, Elav-like family member 4 |
1822 |
0.41 |
chr9_41585694_41587243 | 5.40 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr15_20448699_20449797 | 5.37 |
Cdh12 |
cadherin 12 |
17 |
0.53 |
chr2_65566312_65566743 | 5.37 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
965 |
0.63 |
chr16_63860769_63861945 | 5.33 |
Epha3 |
Eph receptor A3 |
2056 |
0.46 |
chr9_10903129_10903698 | 5.33 |
Gm32710 |
predicted gene, 32710 |
932 |
0.44 |
chr15_25753741_25754105 | 5.29 |
Myo10 |
myosin X |
944 |
0.64 |
chr1_177444257_177446079 | 5.28 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
230 |
0.9 |
chr13_113917613_113918228 | 5.27 |
Arl15 |
ADP-ribosylation factor-like 15 |
123298 |
0.05 |
chr10_90578974_90579573 | 5.25 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
2281 |
0.42 |
chr3_80799469_80799764 | 5.25 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
2963 |
0.34 |
chr16_39985091_39985370 | 5.24 |
Lsamp |
limbic system-associated membrane protein |
635 |
0.81 |
chrX_110811626_110812334 | 5.22 |
Gm44593 |
predicted gene 44593 |
344 |
0.89 |
chrX_143927903_143928408 | 5.19 |
Dcx |
doublecortin |
4895 |
0.3 |
chr3_60527660_60528578 | 5.16 |
Mbnl1 |
muscleblind like splicing factor 1 |
9 |
0.98 |
chr16_42336507_42337221 | 5.15 |
Gap43 |
growth associated protein 43 |
3787 |
0.3 |
chr12_76082482_76082659 | 5.12 |
Syne2 |
spectrin repeat containing, nuclear envelope 2 |
631 |
0.77 |
chr19_44758783_44762005 | 5.09 |
Pax2 |
paired box 2 |
479 |
0.75 |
chr18_76846515_76847871 | 5.04 |
Skor2 |
SKI family transcriptional corepressor 2 |
9212 |
0.25 |
chr6_12118208_12118533 | 5.02 |
Gm6578 |
predicted gene 6578 |
8787 |
0.23 |
chr5_111427829_111429009 | 5.01 |
Gm43119 |
predicted gene 43119 |
4830 |
0.19 |
chr17_29883165_29884481 | 4.99 |
Mdga1 |
MAM domain containing glycosylphosphatidylinositol anchor 1 |
3659 |
0.2 |
chr2_158610228_158611991 | 4.98 |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
342 |
0.44 |
chr11_44900486_44900823 | 4.98 |
Ebf1 |
early B cell factor 1 |
11484 |
0.29 |
chr6_138425601_138426128 | 4.97 |
Lmo3 |
LIM domain only 3 |
952 |
0.54 |
chr3_4796861_4798079 | 4.94 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
88 |
0.98 |
chr4_101354495_101354967 | 4.94 |
0610043K17Rik |
RIKEN cDNA 0610043K17 gene |
948 |
0.35 |
chr18_36194406_36194893 | 4.92 |
Nrg2 |
neuregulin 2 |
2583 |
0.31 |
chr7_36703759_36704512 | 4.91 |
Tshz3 |
teashirt zinc finger family member 3 |
5918 |
0.14 |
chrX_66650823_66651841 | 4.89 |
Slitrk2 |
SLIT and NTRK-like family, member 2 |
1675 |
0.36 |
chrX_59566046_59566497 | 4.87 |
Fgf13 |
fibroblast growth factor 13 |
1201 |
0.64 |
chr13_75089525_75090889 | 4.87 |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
291 |
0.94 |
chr12_49387532_49388566 | 4.87 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
1603 |
0.26 |
chr1_64116857_64117480 | 4.86 |
Klf7 |
Kruppel-like factor 7 (ubiquitous) |
4314 |
0.23 |
chr12_108556541_108556856 | 4.83 |
Gm16596 |
predicted gene, 16596 |
1080 |
0.43 |
chr5_113690253_113690469 | 4.81 |
1700069L16Rik |
RIKEN cDNA 1700069L16 gene |
14087 |
0.13 |
chr1_12988619_12989682 | 4.80 |
Slco5a1 |
solute carrier organic anion transporter family, member 5A1 |
1764 |
0.4 |
chr5_43236846_43237650 | 4.79 |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
67 |
0.96 |
chr11_94044930_94045437 | 4.78 |
Spag9 |
sperm associated antigen 9 |
818 |
0.6 |
chr19_49539725_49539931 | 4.77 |
Gm50444 |
predicted gene, 50444 |
14190 |
0.3 |
chr1_66322822_66322976 | 4.76 |
Map2 |
microtubule-associated protein 2 |
797 |
0.63 |
chr13_105249002_105249192 | 4.76 |
Rnf180 |
ring finger protein 180 |
21942 |
0.21 |
chr13_83717521_83718816 | 4.75 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3213 |
0.17 |
chr4_13747506_13748460 | 4.75 |
Runx1t1 |
RUNX1 translocation partner 1 |
3314 |
0.37 |
chr16_21846848_21847588 | 4.73 |
Gm26744 |
predicted gene, 26744 |
1442 |
0.29 |
chr14_66865047_66865736 | 4.72 |
Dpysl2 |
dihydropyrimidinase-like 2 |
3297 |
0.19 |
chr2_105678552_105679922 | 4.72 |
Pax6 |
paired box 6 |
630 |
0.68 |
chr7_87586513_87587584 | 4.69 |
Grm5 |
glutamate receptor, metabotropic 5 |
2650 |
0.4 |
chr1_81077232_81078427 | 4.69 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
4.0 | 12.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.1 | 9.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
3.1 | 9.3 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
3.1 | 9.2 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
2.9 | 11.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.9 | 11.6 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.8 | 11.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
2.6 | 7.7 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
2.3 | 6.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.2 | 10.9 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
1.9 | 5.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.9 | 5.7 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.9 | 5.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.9 | 3.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.9 | 5.7 | GO:0007525 | somatic muscle development(GO:0007525) |
1.9 | 5.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.8 | 17.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.6 | 4.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.6 | 4.8 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.5 | 7.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.5 | 8.9 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.4 | 5.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.4 | 7.0 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.4 | 2.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.4 | 8.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.3 | 4.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.3 | 10.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.3 | 12.7 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
1.3 | 3.8 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.3 | 5.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.2 | 4.9 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.2 | 3.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.2 | 8.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.2 | 3.6 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.2 | 9.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.2 | 1.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.1 | 5.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.1 | 3.4 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.1 | 5.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.1 | 3.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.1 | 2.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.1 | 2.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
1.1 | 5.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.0 | 21.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.0 | 2.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.0 | 12.9 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.0 | 4.9 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.0 | 11.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.0 | 4.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.0 | 3.8 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.9 | 5.6 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.9 | 2.8 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.9 | 3.7 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.9 | 14.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.9 | 1.8 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.9 | 3.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.9 | 1.7 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.9 | 0.9 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.9 | 4.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.8 | 2.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.8 | 4.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.8 | 2.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.8 | 4.1 | GO:0060023 | soft palate development(GO:0060023) |
0.8 | 4.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.8 | 8.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.8 | 1.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.8 | 8.6 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.8 | 2.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.8 | 2.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.8 | 0.8 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.7 | 3.0 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.7 | 2.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.7 | 4.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 5.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.7 | 2.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.7 | 2.1 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.7 | 4.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.7 | 2.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.7 | 2.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.6 | 3.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.6 | 1.9 | GO:0030070 | insulin processing(GO:0030070) |
0.6 | 1.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.6 | 3.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.6 | 2.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.6 | 2.4 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.6 | 0.6 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.6 | 0.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.6 | 5.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.6 | 1.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 2.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.6 | 4.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.6 | 1.8 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.6 | 3.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.6 | 2.9 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.6 | 5.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.6 | 1.7 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.6 | 3.4 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.6 | 2.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.6 | 2.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 1.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.5 | 2.7 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.5 | 3.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.5 | 6.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 18.0 | GO:0021766 | hippocampus development(GO:0021766) |
0.5 | 3.2 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.5 | 11.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.5 | 1.0 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.5 | 0.5 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.5 | 1.0 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.5 | 5.0 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.5 | 1.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.5 | 1.9 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 1.5 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 9.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.5 | 1.0 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.5 | 4.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.5 | 1.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.5 | 1.9 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 1.9 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.5 | 3.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.5 | 0.5 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.4 | 1.8 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.4 | 4.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 2.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 1.7 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.4 | 2.6 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.4 | 3.4 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.4 | 0.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 1.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 1.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 12.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.4 | 4.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.4 | 1.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.4 | 16.6 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.4 | 36.2 | GO:0007612 | learning(GO:0007612) |
0.4 | 2.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.4 | 17.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 0.8 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 2.6 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 1.8 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.4 | 2.6 | GO:0060074 | synapse maturation(GO:0060074) |
0.4 | 1.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.4 | 1.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 1.8 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.4 | 0.4 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.4 | 2.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 3.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 0.7 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.3 | 2.1 | GO:0015816 | glycine transport(GO:0015816) |
0.3 | 5.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 24.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 1.0 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.3 | 2.4 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 1.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 1.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 1.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 0.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.3 | 10.7 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.3 | 1.6 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.3 | 0.3 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.3 | 0.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 3.5 | GO:0046847 | filopodium assembly(GO:0046847) |
0.3 | 0.6 | GO:0014075 | response to amine(GO:0014075) |
0.3 | 1.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 0.6 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.3 | 2.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.3 | 2.2 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.3 | 0.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 1.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.3 | 0.3 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.3 | 0.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.3 | 0.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.3 | 0.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.3 | 0.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 2.6 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.3 | 2.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.8 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.3 | 0.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.3 | 0.6 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.3 | 0.6 | GO:0045991 | carbon catabolite activation of transcription(GO:0045991) |
0.3 | 0.8 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 3.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 0.5 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 0.8 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.3 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 0.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.3 | 1.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.3 | 0.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 1.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 0.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.2 | 2.0 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.7 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 0.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 0.7 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.2 | 1.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.2 | 1.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.2 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
0.2 | 0.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 1.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 1.1 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.2 | 1.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 1.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 1.1 | GO:0042711 | maternal behavior(GO:0042711) |
0.2 | 1.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 0.7 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 0.4 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.4 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 1.5 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.2 | 3.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 0.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 0.6 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 1.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.2 | 1.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 1.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 1.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 0.2 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 1.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 1.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 1.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.2 | 1.4 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.2 | 0.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 1.8 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.2 | 0.2 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.2 | 1.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 1.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 1.4 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 0.4 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 0.8 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 1.4 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.2 | 0.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 0.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 0.4 | GO:0060594 | mammary gland specification(GO:0060594) |
0.2 | 0.4 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 0.4 | GO:0007632 | visual behavior(GO:0007632) |
0.2 | 0.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 4.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 1.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 0.3 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.2 | 0.3 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.2 | 1.0 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 0.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.8 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.5 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 0.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 1.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.2 | 0.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.2 | 0.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 1.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.3 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 0.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 0.6 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.2 | 0.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 0.3 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 1.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.2 | 1.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.3 | GO:0033483 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.2 | 0.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 0.5 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 0.9 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 0.8 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 0.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 4.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 0.3 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.6 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 0.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.4 | GO:0072017 | distal tubule development(GO:0072017) |
0.1 | 1.5 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.4 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 1.7 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 2.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.4 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 1.6 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.5 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.7 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 2.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 1.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.1 | 0.3 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.9 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.9 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 3.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.7 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 2.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 0.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 2.4 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 2.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.8 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 1.6 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 1.8 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 1.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.2 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.1 | 0.8 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.1 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.8 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 10.0 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.4 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 2.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.6 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 1.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 3.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 3.9 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.9 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.4 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 2.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.7 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.5 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 1.4 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 1.1 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.8 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.3 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 4.0 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.1 | 1.0 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.3 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.1 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.1 | 0.1 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 0.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.8 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.1 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.7 | GO:0051904 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.1 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.1 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 1.0 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.7 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.1 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.1 | 2.9 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.1 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 1.0 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 0.9 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
0.1 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.6 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 1.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.1 | 0.3 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.2 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.6 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.1 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.1 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.1 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.8 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 1.3 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.1 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.1 | 0.2 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.1 | GO:2001026 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) regulation of endothelial cell chemotaxis(GO:2001026) |
0.1 | 0.2 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 0.1 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.1 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.3 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 1.2 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.3 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.2 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 2.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.1 | GO:1900042 | regulation of interleukin-2 secretion(GO:1900040) positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.1 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.1 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.4 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.0 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.1 | GO:2000544 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.2 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.0 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.0 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 1.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.0 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.0 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.0 | 0.0 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.0 | 0.0 | GO:0021544 | subpallium development(GO:0021544) |
0.0 | 0.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.0 | 0.3 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.9 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.6 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.1 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.0 | 1.4 | GO:0050808 | synapse organization(GO:0050808) |
0.0 | 0.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 0.2 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.6 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.0 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.3 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.0 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.0 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.2 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.2 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.0 | 0.0 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.0 | 0.2 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.0 | GO:0061738 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) late endosomal microautophagy(GO:0061738) |
0.0 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.4 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.2 | GO:0019076 | viral release from host cell(GO:0019076) |
0.0 | 0.1 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.2 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.0 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 1.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.0 | 0.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 0.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.0 | 0.0 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.0 | 0.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.1 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.0 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.0 | GO:0070432 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.0 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.0 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.0 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of hypersensitivity(GO:0002884) |
0.0 | 0.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.0 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 0.4 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.0 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.3 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.0 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 0.0 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.0 | 0.0 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.8 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.0 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.0 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.0 | 0.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.0 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 1.2 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.0 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.0 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.0 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.1 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.0 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.0 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.2 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.0 | 0.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.0 | 0.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.1 | GO:0031280 | negative regulation of cyclase activity(GO:0031280) |
0.0 | 0.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 1.6 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
0.0 | 0.0 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.0 | 0.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 20.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.7 | 17.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.3 | 3.8 | GO:0072534 | perineuronal net(GO:0072534) |
1.2 | 18.4 | GO:0031527 | filopodium membrane(GO:0031527) |
1.2 | 3.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.2 | 3.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.2 | 9.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.2 | 9.4 | GO:0043083 | synaptic cleft(GO:0043083) |
1.1 | 2.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.0 | 1.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.0 | 6.0 | GO:0005915 | zonula adherens(GO:0005915) |
0.9 | 13.4 | GO:0031045 | dense core granule(GO:0031045) |
0.9 | 3.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.9 | 15.3 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.8 | 27.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.8 | 4.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.8 | 2.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.7 | 5.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.7 | 3.7 | GO:0097433 | dense body(GO:0097433) |
0.7 | 1.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.7 | 3.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.7 | 33.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 8.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 19.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.6 | 3.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 5.0 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 4.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.6 | 19.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.6 | 18.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.6 | 6.0 | GO:0097449 | astrocyte projection(GO:0097449) |
0.6 | 1.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.5 | 1.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.5 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 11.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.5 | 4.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 4.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 1.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.4 | 1.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.4 | 9.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 20.1 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 20.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 2.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 45.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 4.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 0.6 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 0.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 2.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 0.6 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 1.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 26.0 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 2.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 1.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 3.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 2.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 0.8 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 0.7 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 1.2 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 33.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 2.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 0.7 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.2 | 9.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.4 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 4.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 1.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 10.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 1.0 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 6.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.7 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 4.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 2.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.9 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 1.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 4.6 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.2 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 1.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 1.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.2 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.4 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.7 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.4 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.5 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 6.6 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.0 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.0 | 0.0 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.9 | 20.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.8 | 18.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
3.1 | 9.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.9 | 8.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.3 | 7.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.9 | 13.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.7 | 9.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.5 | 9.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.2 | 4.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.2 | 4.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.1 | 3.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.1 | 13.0 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.1 | 26.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.0 | 3.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.0 | 4.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.0 | 10.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.0 | 2.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.0 | 12.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.9 | 8.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.9 | 3.7 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.9 | 5.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.9 | 2.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.9 | 2.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.9 | 3.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.8 | 2.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.8 | 4.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.8 | 2.4 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.8 | 9.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.8 | 3.8 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.7 | 2.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.7 | 5.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 2.9 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.7 | 3.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.7 | 6.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 8.8 | GO:0031005 | filamin binding(GO:0031005) |
0.7 | 3.9 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.7 | 5.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.7 | 7.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 3.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 1.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 4.3 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 16.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.6 | 1.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.6 | 1.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.6 | 2.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 1.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 4.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 8.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.5 | 1.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 2.0 | GO:0015265 | urea channel activity(GO:0015265) |
0.5 | 1.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.5 | 6.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 2.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 9.8 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.5 | 11.5 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.5 | 8.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 3.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 0.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 2.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.4 | 1.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 4.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.4 | 3.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 1.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.4 | 2.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.4 | 2.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.4 | 2.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 1.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 1.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.4 | 1.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.4 | 2.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 0.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.3 | 1.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 5.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 3.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 0.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 1.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 8.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 1.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 0.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.9 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 1.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 1.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 1.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 7.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 5.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 2.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 3.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 0.7 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 0.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 1.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 6.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.7 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.7 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 5.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 5.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 0.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 0.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 2.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 2.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 1.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 1.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 4.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 2.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 1.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 3.0 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 3.3 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 2.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 2.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 0.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 3.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 1.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 0.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 1.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 4.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 1.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 3.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 2.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 5.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.6 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 3.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 2.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 2.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.3 | GO:0008066 | ionotropic glutamate receptor activity(GO:0004970) glutamate receptor activity(GO:0008066) |
0.1 | 0.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 2.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.4 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 1.8 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 3.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 2.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 2.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.9 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 4.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 1.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.7 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 1.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 6.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 4.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 1.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 1.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.6 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 2.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 1.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.6 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 1.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 6.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.5 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 2.3 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 1.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 3.2 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.2 | GO:1901338 | catecholamine binding(GO:1901338) |
0.1 | 0.3 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 0.5 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 8.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.7 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 1.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 1.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 0.5 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.1 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 2.0 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.1 | GO:0018565 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 1.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 0.2 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.5 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 1.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.9 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.0 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 2.7 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.0 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.0 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.0 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.0 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.0 | 0.0 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.0 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 1.2 | ST ADRENERGIC | Adrenergic Pathway |
0.6 | 36.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.6 | 19.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 18.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.4 | 4.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 5.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 2.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 8.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 7.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 6.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 2.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 3.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 8.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 7.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 5.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 1.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 2.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 4.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.9 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.7 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 2.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 6.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 1.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 31.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.1 | 1.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.8 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.8 | 11.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.8 | 10.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 5.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.6 | 16.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.6 | 0.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.6 | 7.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.6 | 7.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.6 | 10.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.6 | 4.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.6 | 12.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 11.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.5 | 3.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 3.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.5 | 9.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 3.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 15.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 9.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 2.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 2.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 2.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 1.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 9.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 1.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 1.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 1.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 11.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 3.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 2.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 6.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 0.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 0.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 1.3 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.2 | 2.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 11.1 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 1.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 1.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 3.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 4.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 1.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 3.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 3.1 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 1.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 1.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.8 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 11.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 1.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.8 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.3 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 1.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.6 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.0 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.0 | 0.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |